Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TWLO vs GSK✓SelectedUSD · GSKTWLO vs GSK performance historyLatest closeAs of-8.75%11/19
Stock and ETF performance explorer

TWLO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+385.8%
GSK return
+97.7%
Excess return
+288.2%
Maximum drawdown
-90.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.8%-1.6%-7.2%-8.4%
7D-15.8%-4.7%-11.0%-14.9%
30D-30.9%-4.7%-26.2%-30.3%
3M-19.4%-8.8%-10.7%-18.0%
6M-8.8%-4.6%-4.1%-8.3%
YTD+25.7%+1.0%+24.7%+23.4%
1Y+48.8%+6.9%+41.9%+43.9%
3Y+183.3%+52.5%+130.7%+140.4%
5Y-37.3%+40.3%-77.6%-46.1%
All+385.8%+97.7%+288.2%+279.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling